MSInsight explores the diagnostic potential of microsatellites
MSInsight is proud to be featured on Biologiste365, where we share our innovative work in advancing the diagnostic space for microsatellites. Our solution, MSIcare, uses next-generation sequencing to detect microsatellite instability (MSI), a key biomarker for predicting patient responses to precision oncology treatments.
We are thrilled to contribute to the evolution of oncology diagnostics by improving treatment decisions and patient outcomes.
A big thank you to Biologiste365 for spotlighting our mission and innovation!
